Japanese Drugmakers Strengthen Area Ties
10/19/2005 5:13:10 PM
More...
|
Fujisawa Healthcare, Inc. And Roche (RHHBY) Announce Co-promotion Of MYCAMINE(TM)
10/19/2005 5:13:10 PM
More...
|
Fujisawa Healthcare, Inc. Release: Mycamine(TM) Receives FDA Approval
10/19/2005 5:13:03 PM
More...
|
FDA Cautions Doctors On Eczema Treatment
10/19/2005 5:12:59 PM
More...
|
Cardiome Receives US$6 Million Milestone Payment
10/19/2005 5:12:49 PM
More...
|
US FDA Should Warn About Eczema Drug Risk-Panel
10/19/2005 5:12:45 PM
More...
|
Phase Forward Partners With Fujitsu To Promote InForm EDC Solution In Japan
10/19/2005 5:11:42 PM
More...
|
Fujisawa Healthcare Release: Ninety Six Percent Patient Survival Rate Shown In First-Ever Multi-Center, Double-Blind Study Of Early Steroid Withdrawal In Kidney Transplant Recipients
10/19/2005 5:11:26 PM
More...
|
Fujisawa Healthcare Release: Clinical Study Shows Safe And Well-Tolerated Conversion To Once Daily Tacrolimus From The Standard Prograf (Tacrolimus) Regimen In Stable Liver Transplant Recipients
10/19/2005 5:11:22 PM
More...
|
Fujisawa Healthcare Submits NDA For Treatment Of Esophageal Candidiasis
10/19/2005 5:11:04 PM
More...
|
|